209 related articles for article (PubMed ID: 30978432)
1. Combining activatable nanodelivery with immunotherapy in a murine breast cancer model.
Kheirolomoom A; Silvestrini MT; Ingham ES; Mahakian LM; Tam SM; Tumbale SK; Foiret J; Hubbard NE; Borowsky AD; Ferrara KW
J Control Release; 2019 Jun; 303():42-54. PubMed ID: 30978432
[TBL] [Abstract][Full Text] [Related]
2. CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery.
Kheirolomoom A; Ingham ES; Mahakian LM; Tam SM; Silvestrini MT; Tumbale SK; Foiret J; Hubbard NE; Borowsky AD; Murphy WJ; Ferrara KW
J Control Release; 2015 Dec; 220(Pt A):253-264. PubMed ID: 26471394
[TBL] [Abstract][Full Text] [Related]
3. Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia.
Kheirolomoom A; Lai CY; Tam SM; Mahakian LM; Ingham ES; Watson KD; Ferrara KW
J Control Release; 2013 Nov; 172(1):266-273. PubMed ID: 23994755
[TBL] [Abstract][Full Text] [Related]
4. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
5. Intracellular trafficking of a pH-responsive drug metal complex.
Kheirolomoom A; Ingham ES; Commisso J; Abushaban N; Ferrara KW
J Control Release; 2016 Dec; 243():232-242. PubMed ID: 27746275
[TBL] [Abstract][Full Text] [Related]
6. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.
Fite BZ; Kheirolomoom A; Foiret JL; Seo JW; Mahakian LM; Ingham ES; Tam SM; Borowsky AD; Curry FE; Ferrara KW
J Control Release; 2017 Jun; 256():203-213. PubMed ID: 28395970
[TBL] [Abstract][Full Text] [Related]
10. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect.
Dromi S; Frenkel V; Luk A; Traughber B; Angstadt M; Bur M; Poff J; Xie J; Libutti SK; Li KC; Wood BJ
Clin Cancer Res; 2007 May; 13(9):2722-7. PubMed ID: 17473205
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy.
Ning S; Macleod K; Abra RM; Huang AH; Hahn GM
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030
[TBL] [Abstract][Full Text] [Related]
12. Harnessing immunotherapy to enhance the systemic anti-tumor effects of thermosensitive liposomes.
Regenold M; Wang X; Kaneko K; Bannigan P; Allen C
Drug Deliv Transl Res; 2023 Apr; 13(4):1059-1073. PubMed ID: 36577832
[TBL] [Abstract][Full Text] [Related]
13. Liposomal doxorubicin combined with regional hyperthermia: reducing systemic toxicity and improving locoregional efficacy in the treatment of solid tumors.
Dvorak J; Zoul Z; Melichar B; Petera J; Vesely P; Vosmik M; Dolezel M
J Chemother; 2004 Nov; 16 Suppl 5():34-6. PubMed ID: 15675474
[TBL] [Abstract][Full Text] [Related]
14. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
[TBL] [Abstract][Full Text] [Related]
16. Comparing the therapeutic potential of thermosensitive liposomes and hyperthermia in two distinct subtypes of breast cancer.
Lokerse WJM; Bolkestein M; Dalm SU; Eggermont AMM; de Jong M; Grüll H; Koning GA
J Control Release; 2017 Jul; 258():34-42. PubMed ID: 28479096
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
[TBL] [Abstract][Full Text] [Related]
18. The comparative effect of wrapping solid gold nanoparticles and hollow gold nanoparticles with doxorubicin-loaded thermosensitive liposomes for cancer thermo-chemotherapy.
Li Y; He D; Tu J; Wang R; Zu C; Chen Y; Yang W; Shi D; Webster TJ; Shen Y
Nanoscale; 2018 May; 10(18):8628-8641. PubMed ID: 29697100
[TBL] [Abstract][Full Text] [Related]
19. Effect of High-Intensity Focused Ultrasound on Drug Release from Doxorubicin-Loaded PEGylated Liposomes and Therapeutic Effect in Colorectal Cancer Murine Models.
Jeong HS; Hwang H; Oh PS; Kim EM; Lee TK; Kim M; Kim HS; Lim ST; Sohn MH; Jeong HJ
Ultrasound Med Biol; 2016 Apr; 42(4):947-55. PubMed ID: 26795498
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia.
Al-Ahmady ZS; Chaloin O; Kostarelos K
J Control Release; 2014 Dec; 196():332-43. PubMed ID: 25456832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
